Plasma brain natriuretic peptide as a biomarker for haemodynamic outcome and mortality following pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension | Zendy

Sulaiman Surie | Zendy; Herre J. Reesink | Zendy; Mart N. van der Plas | Zendy; Maxim Hardziyenka | Zendy; Jaap J. Kloek | Zendy; Aeilko H. Zwinderman | Zendy; Paul Bresser | Zendy

Open Access

Plasma brain natriuretic peptide as a biomarker for haemodynamic outcome and mortality following pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension

Author(s) -

Sulaiman Surie,

Herre J. Reesink,

Mart N. van der Plas,

Maxim Hardziyenka,

Jaap J. Kloek,

Aeilko H. Zwinderman,

Paul Bresser

Publication year - 2012

Publication title -

interactive cardiovascular and thoracic surgery

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.546

H-Index - 56

eISSN - 1569-9293

pISSN - 1569-9285

DOI - 10.1093/icvts/ivs415

Subject(s) - medicine , brain natriuretic peptide , cardiology , ejection fraction , pulmonary hypertension , biomarker , natriuretic peptide , intensive care unit , hemodynamics , heart failure , biochemistry , chemistry

In chronic thromboembolic pulmonary hypertension (CTEPH), right ventricular (RV) dysfunction is associated with increased morbidity and mortality following pulmonary endarterectomy. Plasma brain natriuretic peptide (BNP) levels were previously shown to correlate with RV (dys)function. We hypothesized that BNP can be used as a non-invasive biomarker to identify patients at 'high risk' for postoperative morbidity and mortality.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research